ClinicalTrials.Veeva

Menu

Survival Validation and Gene Mutations of N Descriptors in the Ninth Edition of the TNM Classification for Lung Cancer

Fudan University logo

Fudan University

Status

Enrolling

Conditions

Non-small Cell Lung Cancer

Treatments

Procedure: Radical resection

Study type

Observational

Funder types

Other

Identifiers

NCT06349252
LUNGTNM

Details and patient eligibility

About

The International Association for the Study of Lung Cancer Staging Committee recently unveiled the ninth edition of TNM staging system for lung cancer. This study aims to explore survival outcomes, stage grouping, and gene mutations in N descriptors of this new classification system.

Enrollment

1,263 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

Pathological N2.

Exclusion criteria

Patients undergoing neoadjuvant chemotherapy

Trial contacts and locations

1

Loading...

Central trial contact

Fangqiu Fu, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems